Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 133 record(s)

Req # A-2021-000319

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103408-98.

Organization: Health Canada

10 page(s)
August 2021

Req # A-2021-000324

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104166-647.

Organization: Health Canada

15 page(s)
August 2021

Req # A-2021-000338

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103404-913.

Organization: Health Canada

9 page(s)
August 2021

Req # A-2021-000347

Adverse Drug Reaction (ADR) for ZOLPIDEM TARTRATE. Report number: E2B_03415858.

Organization: Health Canada

23 page(s)
August 2021

Req # A-2021-000348

Adverse Drug Reaction (ADR) for CROMOGLICATE SODIUM. Report number: E2B_03387488.

Organization: Health Canada

40 page(s)
August 2021

Req # A-2021-000351

Adverse Reaction Reports (AERs) for GLYCERYL TRINITRATE. Report numbers: E2B_03564299, E2B_03639641.

Organization: Health Canada

45 page(s)
August 2021

Req # A-2021-000352

Adverse Reaction Reports (AERs) for DESOXIMETASONE. Report numbers: E2B_03706173, E2B_03706156.

Organization: Health Canada

68 page(s)
August 2021

Req # A-2021-000365

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03829948.

Organization: Health Canada

17 page(s)
August 2021

Req # A-2021-000391

Adverse Drug Reaction (ADR) for Misoprostol. Report number: 000939353.

Organization: Health Canada

3 page(s)
August 2021

Req # A-2021-000407

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106413-934.

Organization: Health Canada

194 page(s)
August 2021
Date modified: